Skip to main content

Ethicon Mesh Alleged For Infections, Recurrent Hernia

Ethicon Mesh Alleged For Infections, Recurrent Hernia

Ethicon Mesh Alleged For Infections, Recurrent Hernia

Introduction

On June 13, a Florida woman filed a lawsuit against Johnson & Johnson (J&J) and its Ethicon subsidiary for selling defective and substandard hernia mesh implants.

According to the court documents, the woman underwent surgery to implant a medium-sized version of the Prolene Hernia System in February 2005. Four years later, the surgeons had to remove the hernia mesh following infections, recurrent hernia, and other complications allegedly caused due to the implant. The lawsuit also indicates the woman was at a higher risk of severe complications during abdominal surgery and warns that she may be unable to undergo further abdominal surgeries even if needed. The said failure in the plaintiff’s device was due to the misleading marketing and warrant about the mesh design and composition.

All Ethicon hernia mesh lawsuits are consolidated under MDL No. 2327 (In Re: Ethicon Inc., Pelvic Repair System Products Liability Litigation). Similar allegations have been raised against Bard hernia mesh and Atrium C-Qur mesh. Bard hernia mesh lawsuits are consolidated under MDL No. 2846; Atrium C-Qur mesh lawsuits are consolidated under MDL No. 2753.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!